Matsumoto K, Yamamoto T, Kamata R, Maeda H
Adv Exp Med Biol. 1986;198 Pt B:71-8. doi: 10.1007/978-1-4757-0154-8_9.
A zinc dependent serratial 56K protease caused enhancement of vascular permeability followed by edema formation when injected into the guinea pig peripheral cornea, the subconjunctival space, or the skin. Because this enhancement was not affected by antihistamine, involvement of the kinin-generating system in this permeability enhancement was investigated. The 56K protease induced permeability much greater extent than that by bradykinin on weight basis, and more so on molar basis. The phenomenon was inhibited by soybean trypsin inhibitor, a well known inhibitor of plasma kallikrein, and also by corn trypsin inhibitor, which is the best inhibitor of the activated Hageman factor. In vitro experiments using numbers of synthetic peptide substrates, the 56K protease exhibited a similar substrate specificity to that of plasma kallikrein. Kallikrein is a known endogenous activator of Hageman factor. The enhancement by 56K protease was greatly augmented by inhibition of kininase II with Glu-Trp-Arg-Pro-Gln-Ile-Pro-Pro-OH (SQ 20,881), suggesting generation of bradykinin. Thus, these results indicate that the enhancement of vascular permeability induced by the 56K protease is caused by an activation of Hageman factor by 56K protease followed by subsequent activation of cascade amplification, and resulted in kinin generation in vivo.
一种锌依赖性的粘质沙雷氏菌56K蛋白酶,当注射到豚鼠外周角膜、结膜下间隙或皮肤中时,会导致血管通透性增强,随后形成水肿。由于这种增强不受抗组胺药的影响,因此研究了激肽生成系统在这种通透性增强中的作用。56K蛋白酶在重量基础上比缓激肽诱导的通透性程度更大,在摩尔基础上更是如此。这种现象被大豆胰蛋白酶抑制剂(一种众所周知的血浆激肽释放酶抑制剂)以及玉米胰蛋白酶抑制剂(活化的哈格曼因子的最佳抑制剂)所抑制。使用多种合成肽底物进行的体外实验表明,56K蛋白酶表现出与血浆激肽释放酶相似的底物特异性。激肽释放酶是已知的哈格曼因子的内源性激活剂。用Glu-Trp-Arg-Pro-Gln-Ile-Pro-Pro-OH(SQ 20,881)抑制激肽酶II可大大增强56K蛋白酶引起的通透性增强,提示缓激肽的生成。因此,这些结果表明,56K蛋白酶诱导的血管通透性增强是由56K蛋白酶激活哈格曼因子,随后激活级联放大反应,并在体内导致激肽生成所致。